High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for patients with previously irradiated recurrent medulloblastoma

被引:0
|
作者
Dunkel, Ira [1 ]
Gardner, Sharon [2 ]
Garvin, James [3 ]
Goldman, Stewart [4 ]
Shi, Weiji [1 ]
Finlay, Jonathan [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
[4] Childrens Mem Hosp, Chicago, IL 60614 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:480 / 480
页数:1
相关论文
共 50 条
  • [31] Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer
    Minichmayr, Iris
    Nock, Valerie
    Jaehde, Ulrich
    Kloft, Charlotte
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 74 - 76
  • [32] Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors
    Finlay, JL
    Goldman, S
    Wong, MC
    Cairo, M
    Garvin, J
    August, C
    Cohen, BH
    Stanley, P
    Zimmerman, RA
    Bostrom, B
    Geyer, JR
    Harris, RE
    Sanders, J
    Yates, AJ
    Boyett, JM
    Packer, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) : 2495 - 2503
  • [33] High-dose thiotepa, melphalan and carboplatin followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - a retrospective evaluation
    Demirer, T
    Soydan, E
    Fen, T
    Ilhan, O
    Ayli, M
    Arat, M
    Ozcan, M
    Gunel, N
    Arslan, O
    Genc, Y
    Uysal, A
    Haznedar, R
    Buyukberber, S
    Gurman, G
    Ustaer, N
    Hazar, B
    Ozet, G
    Akan, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S250
  • [34] CUTANEOUS TOXICITY OF HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION
    BEYER, J
    GRABBE, J
    LENZ, K
    WEISBACH, V
    STROHSCHEER, I
    HUHN, D
    SIEGERT, W
    BONE MARROW TRANSPLANTATION, 1992, 10 (06) : 491 - 494
  • [35] Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support
    Lotz, JP
    Izrael, V
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 858 - 859
  • [36] High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma
    Hong, C. R.
    Kang, H. J.
    Kim, M. S.
    Ju, H. Y.
    Lee, J. W.
    Kim, H.
    Kim, H-S
    Park, S-H
    Park, K. D.
    Park, J. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2015, 50 (10) : 1375 - 1378
  • [37] High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma
    C R Hong
    H J Kang
    M S Kim
    H Y Ju
    J W Lee
    H Kim
    H-S Kim
    S-H Park
    K D Park
    J D Park
    H Y Shin
    H S Ahn
    Bone Marrow Transplantation, 2015, 50 : 1375 - 1378
  • [38] Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma
    MI Zia
    P Forsyth
    A Chaudhry
    J Russell
    DA Stewart
    Bone Marrow Transplantation, 2002, 30 : 565 - 569
  • [39] Adult medulloblastoma: feasibility and effectiveness of utilising high-dose chemotherapy with autologous stem cell rescue in newly diagnosed patients
    Collins, J. T.
    Narayana, M. J.
    Morris, K.
    Casey, J.
    Inglis, P. -L.
    Cheuk, R.
    Rajah, T.
    Robertson, T.
    Kennedy, G. A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (02) : 209 - 210
  • [40] High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study
    S Kleiner
    A Kirsch
    I Schwaner
    D Kingreen
    N Schwella
    D Huhn
    W Siegert
    Bone Marrow Transplantation, 1997, 20 : 953 - 959